147 related articles for article (PubMed ID: 18074906)
1. Decision making about operability in non-small cell lung cancer.
Van Schil P; Hendriks J; De Maeseneer M; Vandenbroeck Ch; Lauwers P
Acta Chir Belg; 2007; 107(5):495-9. PubMed ID: 18074906
[TBL] [Abstract][Full Text] [Related]
2. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
3. Pre- and intra-operative mediastinal staging in non-small-cell lung cancer.
Lardinois D
Swiss Med Wkly; 2011; 141():w13168. PubMed ID: 21384283
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
[TBL] [Abstract][Full Text] [Related]
5. Remediastinoscopy in restaging of lung cancer after induction therapy.
Marra A; Hillejan L; Fechner S; Stamatis G
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):843-9. PubMed ID: 18374765
[TBL] [Abstract][Full Text] [Related]
6. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.
De Waele M; Hendriks J; Lauwers P; Ortmanns P; Vanroelen W; Morel AM; Germonpré P; Van Schil P
Eur J Cardiothorac Surg; 2006 Feb; 29(2):240-3. PubMed ID: 16386916
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
[TBL] [Abstract][Full Text] [Related]
8. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
[TBL] [Abstract][Full Text] [Related]
9. Operative staging of lung cancer.
Van Schil PE; Van den Brande F; De Maeseneer MG
Monaldi Arch Chest Dis; 2000 Aug; 55(4):299-304. PubMed ID: 11057083
[TBL] [Abstract][Full Text] [Related]
10. Remediastinoscopy.
Van Schil P; De Waele M; Hendriks J; Lauwers P
J Thorac Oncol; 2007 Apr; 2(4):365-6. PubMed ID: 17409813
[TBL] [Abstract][Full Text] [Related]
11. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
12. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.
Rusch VW; Albain KS; Crowley JJ; Rice TW; Lonchyna V; McKenna R; Livingston RB; Griffin BR; Benfield JR
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):97-104; discussion 104-6. PubMed ID: 8380477
[TBL] [Abstract][Full Text] [Related]
14. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
Magnanelli G; Scanagatta P; Benato C; Terzi A; Lonardoni A; Falezza G; Furlan G; Calabrò F
Chir Ital; 2006; 58(1):19-22. PubMed ID: 16729605
[TBL] [Abstract][Full Text] [Related]
15. Extended surgical resection in stage III non-small cell lung cancer.
Hillinger S; Weder W
Front Radiat Ther Oncol; 2010; 42():115-121. PubMed ID: 19955797
[TBL] [Abstract][Full Text] [Related]
16. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.
De Leyn P; Dooms C; Kuzdzal J; Lardinois D; Passlick B; Rami-Porta R; Turna A; Van Schil P; Venuta F; Waller D; Weder W; Zielinski M
Eur J Cardiothorac Surg; 2014 May; 45(5):787-98. PubMed ID: 24578407
[TBL] [Abstract][Full Text] [Related]
17. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
18. Role of surgery in N2 NSCLC: pros.
Shien K; Toyooka S
Jpn J Clin Oncol; 2016 Dec; 46(12):1168-1173. PubMed ID: 27655902
[TBL] [Abstract][Full Text] [Related]
19. [Stage III NSCLC. The surgeon's role in exploration and treatment].
van Schil P; de Waele M; Hendriks J; Lauwers P
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S88-94. PubMed ID: 18971831
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
